Lv3
284 积分 2024-10-09 加入
The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes
29天前
已关闭
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
1个月前
已完结
Transcriptome-wide Mendelian randomization and single-cell analysis during CD4+ T cell activation deciphers immunotherapeutic targets for colorectal cancer
1个月前
已完结
Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems
1个月前
已完结
Angiogenesis Inhibitors
1个月前
已完结
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population
2个月前
已完结
Ten-year Overall Survival in Resectable Stage-III NSCLC - Results of the Randomized ESPATUE Trial – Long-term Survival and Competing Risk Analysis
2个月前
已关闭
Pericyte phenotype switching in cancer
2个月前
已完结
Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics
2个月前
已完结
Assessing the causal association between 731 immunophenotypes and the risk of colorectal cancer: a Mendelian randomization study
2个月前
已关闭
皖公网安备34019202002308